title: BETting on a new prostate cancer treatment.
authors.affiliation: Michigan Center for Translational Pathology; University of Michigan Medical School; Ann Arbor, MI USA; Department of Pathology; University of Michigan Medical School; Ann Arbor, MI USA.
authors.forename: Irfan A
authors.initials: IA
authors.lastname: Asangani
authors.affiliation: Michigan Center for Translational Pathology; University of Michigan Medical School; Ann Arbor, MI USA; Department of Pathology; University of Michigan Medical School; Ann Arbor, MI USA; Howard Hughes Medical Institute; University of Michigan Medical School; Ann Arbor, MI USA; Comprehensive Cancer Center; University of Michigan Medical School; Ann Arbor, MI USA; Department of Urology; University of Michigan Medical School; Ann Arbor, MI USA.
authors.forename: Arul M
authors.initials: AM
authors.lastname: Chinnaiyan
mesh_terms: D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009687:Nuclear Proteins / Q000737:chemistry*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D014157:Transcription Factors / Q000737:chemistry*; D014230:Triazoles / Q000494:pharmacology*
chemical_list: D001381:Azepines; D009687:Nuclear Proteins; D014157:Transcription Factors; D014230:Triazoles